Levetiracetam Exeltis

Levetiracetam, the active ingredient in Levetiracetam Exeltis, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic, and myoclonic seizures, and is approved for use in adult and pediatric populations.

GNH USA supplies Levetiracetam Exeltis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for essential antiepileptic medicines across global markets.

Levetiracetam is an antiepileptic agent used to control seizure activity in epilepsy.

Partial‑onset seizures: decreases the number and severity of focal seizures in individuals diagnosed with epilepsy. Generalized tonic‑clonic seizures: lowers the occurrence of bilateral convulsive seizures, improving overall seizure control. Myoclonic seizures: reduces the frequency of rapid, involuntary muscle jerks characteristic of myoclonic epilepsy. Adjunct therapy: can be combined with other antiepileptic drugs to enhance overall seizure management.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: feeling of light‑headedness or unsteadiness. - Fatigue: persistent tiredness not relieved by rest. - Headache: mild to moderate cranial pain. - Irritability: increased emotional sensitivity or agitation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, and breathing difficulty. - Stevens‑Johnson syndrome: serious skin reaction with blistering and detachment. - Suicidal thoughts or behavior: emergence of depressive symptoms or urges to self‑harm.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: adjust dose based on creatinine clearance. Hepatic dysfunction: monitor liver function tests periodically. Mood changes: observe for depression, anxiety, or suicidal ideation. Concomitant CNS depressants: use caution as additive sedation may occur. Pregnancy: category B, discuss risk‑benefit with patient. Store at ambient temperature: keep below 25°C in original container, protect from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - Other antiepileptic drugs (e.g., valproate): may require dose adjustments. - Oral contraceptives: may have reduced effectiveness; monitor menstrual cycles.